科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/05/12 | 3,630 | 3,660 | 3,620 | 3,645 | +5 | +0.1% | 119,700 |
| 2023/05/11 | 3,720 | 3,750 | 3,635 | 3,640 | -155 | -4.1% | 178,800 |
| 2023/05/10 | 3,850 | 3,890 | 3,780 | 3,795 | -25 | -0.7% | 191,100 |
| 2023/05/09 | 3,800 | 3,830 | 3,795 | 3,820 | +10 | +0.3% | 63,800 |
| 2023/05/08 | 3,770 | 3,845 | 3,770 | 3,810 | +25 | +0.7% | 62,200 |
| 2023/05/02 | 3,840 | 3,840 | 3,785 | 3,785 | -35 | -0.9% | 69,700 |
| 2023/05/01 | 3,775 | 3,830 | 3,755 | 3,820 | +85 | +2.3% | 89,800 |
| 2023/04/28 | 3,745 | 3,760 | 3,735 | 3,735 | +35 | +0.9% | 93,800 |
| 2023/04/27 | 3,700 | 3,710 | 3,685 | 3,700 | -15 | -0.4% | 66,900 |
| 2023/04/26 | 3,735 | 3,735 | 3,700 | 3,715 | -20 | -0.5% | 53,700 |
| 2023/04/25 | 3,730 | 3,765 | 3,720 | 3,735 | +15 | +0.4% | 62,900 |
| 2023/04/24 | 3,745 | 3,765 | 3,710 | 3,720 | -5 | -0.1% | 54,200 |
| 2023/04/21 | 3,700 | 3,730 | 3,700 | 3,725 | +15 | +0.4% | 53,500 |
| 2023/04/20 | 3,700 | 3,735 | 3,690 | 3,710 | +10 | +0.3% | 47,700 |
| 2023/04/19 | 3,690 | 3,705 | 3,685 | 3,700 | ±0 | ±0% | 52,900 |
| 2023/04/18 | 3,710 | 3,720 | 3,690 | 3,700 | +5 | +0.1% | 65,800 |
| 2023/04/17 | 3,710 | 3,710 | 3,690 | 3,695 | -15 | -0.4% | 53,000 |
| 2023/04/14 | 3,715 | 3,735 | 3,700 | 3,710 | +10 | +0.3% | 92,000 |
| 2023/04/13 | 3,700 | 3,715 | 3,690 | 3,700 | +10 | +0.3% | 49,200 |
| 2023/04/12 | 3,680 | 3,700 | 3,660 | 3,690 | +25 | +0.7% | 92,900 |
| 2023/04/11 | 3,720 | 3,720 | 3,665 | 3,665 | -15 | -0.4% | 42,400 |
| 2023/04/10 | 3,675 | 3,685 | 3,660 | 3,680 | +30 | +0.8% | 36,600 |
| 2023/04/07 | 3,675 | 3,695 | 3,650 | 3,650 | -10 | -0.3% | 41,400 |
| 2023/04/06 | 3,635 | 3,675 | 3,620 | 3,660 | +30 | +0.8% | 87,900 |
| 2023/04/05 | 3,705 | 3,705 | 3,630 | 3,630 | -90 | -2.4% | 94,500 |
| 2023/04/04 | 3,710 | 3,720 | 3,680 | 3,720 | +30 | +0.8% | 130,200 |
| 2023/04/03 | 3,700 | 3,715 | 3,685 | 3,690 | -5 | -0.1% | 106,100 |
| 2023/03/31 | 3,715 | 3,720 | 3,685 | 3,695 | -20 | -0.5% | 76,000 |
| 2023/03/30 | 3,760 | 3,760 | 3,700 | 3,715 | -100 | -2.6% | 62,600 |
| 2023/03/29 | 3,795 | 3,830 | 3,775 | 3,815 | +35 | +0.9% | 88,100 |
| 2023/03/28 | 3,780 | 3,795 | 3,750 | 3,780 | +15 | +0.4% | 53,400 |
| 2023/03/27 | 3,770 | 3,790 | 3,740 | 3,765 | +35 | +0.9% | 78,900 |
| 2023/03/24 | 3,650 | 3,730 | 3,650 | 3,730 | +60 | +1.6% | 63,000 |
| 2023/03/23 | 3,650 | 3,685 | 3,645 | 3,670 | -15 | -0.4% | 47,500 |
| 2023/03/22 | 3,695 | 3,700 | 3,665 | 3,685 | +40 | +1.1% | 63,800 |
| 2023/03/20 | 3,660 | 3,680 | 3,635 | 3,645 | -35 | -1% | 63,600 |
| 2023/03/17 | 3,690 | 3,705 | 3,680 | 3,680 | +5 | +0.1% | 65,100 |
| 2023/03/16 | 3,650 | 3,685 | 3,635 | 3,675 | -40 | -1.1% | 77,500 |
| 2023/03/15 | 3,695 | 3,725 | 3,675 | 3,715 | +20 | +0.5% | 71,900 |
| 2023/03/14 | 3,700 | 3,715 | 3,640 | 3,695 | -50 | -1.3% | 66,100 |
| 2023/03/13 | 3,775 | 3,775 | 3,715 | 3,745 | -50 | -1.3% | 54,400 |
| 2023/03/10 | 3,780 | 3,820 | 3,780 | 3,795 | -20 | -0.5% | 92,200 |
| 2023/03/09 | 3,800 | 3,825 | 3,795 | 3,815 | +40 | +1.1% | 52,500 |
| 2023/03/08 | 3,720 | 3,790 | 3,715 | 3,775 | +50 | +1.3% | 81,000 |
| 2023/03/07 | 3,710 | 3,750 | 3,705 | 3,725 | +20 | +0.5% | 45,000 |
| 2023/03/06 | 3,740 | 3,740 | 3,700 | 3,705 | -5 | -0.1% | 74,300 |
| 2023/03/03 | 3,695 | 3,740 | 3,695 | 3,710 | +50 | +1.4% | 155,200 |
| 2023/03/02 | 3,650 | 3,675 | 3,630 | 3,660 | +40 | +1.1% | 96,400 |
| 2023/03/01 | 3,620 | 3,640 | 3,610 | 3,620 | -5 | -0.1% | 73,200 |
| 2023/02/28 | 3,650 | 3,665 | 3,620 | 3,625 | -40 | -1.1% | 100,400 |
251～
300
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 344,000円 | +4.2% | -21.6% | 4.36% | 23.26倍 | 0.91倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 369,300円 | +1.2% | -6.3% | 3.36% | 10.15倍 | 1.13倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 191,500円 | +56.7% | +357.2% | 0.00% | 17.73倍 | 6.15倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 316,000円 | +9.8% | -12.1% | 2.85% | 12.36倍 | 0.63倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 273,000円 | +14.7% | -28.1% | 2.20% | 11.58倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
